Nordson reported third-quarter fiscal 2026 adjusted earnings of $3.25 per share, up 19.0% year over year and 5.2% above the Zacks Consensus Estimate of $3.09, on revenues of $817.67 million that rose 10.3% and beat the consensus estimate of $779 million by 5.0%. Organic sales increased 11.7% year over year, with record third-quarter sales in each of its three business segments, and backlog was up 35% from the prior-year level. Industrial Precision Solutions revenues rose 4.7% to $367.25 million, Medical and Fluid Solutions revenues increased 5.0% to $230.54 million, and Advanced Technology Solutions revenues surged 28.4% to $219.88 million. Nordson now expects fiscal 2026 sales of $3,035-$3,075 million, up from the prior $2,930-$3,010 million range, and adjusted earnings of $11.80-$12.00 per share, compared with the previous $11.30-$11.80 range, calling for sales growth of 9-10% and adjusted earnings growth of 15-17%. The company also highlighted $1.1 billion of near-term capacity for strategic acquisitions, while net debt leverage improved to 1.7 times trailing 12-month EBITDA from 2.1 times at the end of fiscal 2025.
Nordson CorporationQ3 earnings beat and raised fiscal 2026 guidance on strong organic sales and record segment revenue
China Lesso Group Holdings Ltd
Now Inc